Login to Your Account

Other News To Note

Friday, January 27, 2012
• Hemispherx Biopharma Inc., of Philadelphia, gained regulatory approval in Argentina for genital wart drug Alferon N Injection, which will be marketed under the trade name Naturaferon. The product will be sold by Hemispherx's Latin American partner GP Pharm SA. Alferon N Injection, a natural interferon, is already FDA approved.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription